3,135
Views
24
CrossRef citations to date
0
Altmetric
Original Research

PD-1 related transcriptome profile and clinical outcome in diffuse gliomas

, , , , , , & ORCID Icon show all
Article: e1382792 | Received 14 Jul 2017, Accepted 16 Sep 2017, Published online: 25 Oct 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Le Wang, Chaoqi Zhang, Zhen Zhang, Bing Han, Zhibo Shen, Lifeng Li, Shasha Liu, Xuan Zhao, Fanglei Ye & Yi Zhang. (2018) Specific clinical and immune features of CD68 in glioma via 1,024 samples. Cancer Management and Research 10, pages 6409-6419.
Read now

Articles from other publishers (23)

Jin Wang, Fei Shi & Aijun Shan. (2022) Transcriptome profile and clinical characterization of ICOS expression in gliomas. Frontiers in Oncology 12.
Crossref
Kate Huang, Changjun Rao, Qun Li, Jianglong Lu, Zhangzhang Zhu, Chengde Wang, Ming Tu, Chaodong Shen, Shuizhi Zheng, Xiaofang Chen & Fangfang Lv. (2022) Construction and validation of a glioblastoma prognostic model based on immune-related genes. Frontiers in Neurology 13.
Crossref
Hua Zhu, Xinyao Hu, Shi Feng, Lijuan Gu, Zhihong Jian, Ning Zou & Xiaoxing Xiong. (2022) Predictive value of PIMREG in the prognosis and response to immune checkpoint blockade of glioma patients. Frontiers in Immunology 13.
Crossref
Chunzhao Li, Yi Wang, Lang Long, Peng Zhang, Yang Zhang & Nan Ji. (2022) gp96 Expression in Gliomas and Its Association with Tumor Malignancy and T Cell Infiltrating Level. Journal of Oncology 2022, pages 1-14.
Crossref
Qin Zhang, Chaowei Gao, Jianqiang Shao, Shengze Zhang, Peng Wang & Zunyi Wang. (2022) Molecular and Clinical Characterization of CD80 Expression via Large-Scale Analysis in Breast Cancer. Frontiers in Pharmacology 13.
Crossref
Jie Xu, Fang Liu, Yuntao Li & Liang Shen. (2020) A 1p/19q Codeletion-Associated Immune Signature for Predicting Lower Grade Glioma Prognosis. Cellular and Molecular Neurobiology 42:3, pages 709-722.
Crossref
Benjamin Purow. (2022) Delivering Glioblastoma a Kick—DGKα Inhibition as a Promising Therapeutic Strategy for GBM. Cancers 14:5, pages 1269.
Crossref
Elisha Hayden, Holly Holliday, Rebecca Lehmann, Aaminah Khan, Maria Tsoli, Benjamin S. Rayner & David S. Ziegler. (2021) Therapeutic Targets in Diffuse Midline Gliomas—An Emerging Landscape. Cancers 13:24, pages 6251.
Crossref
Xuyan Pan, Zhaopeng Wang, Fang Liu, Feihui Zou, Qijun Xie, Yizhuo Guo & Liang Shen. (2021) A novel tailored immune gene pairs signature for overall survival prediction in lower-grade gliomas. Translational Oncology 14:7, pages 101109.
Crossref
Zhuoyu Zhang, Lunan Liu, Chao Ma, Xin Cui, Raymond H. W. Lam & Weiqiang Chen. (2021) An In Silico Glioblastoma Microenvironment Model Dissects the Immunological Mechanisms of Resistance to PD‐1 Checkpoint Blockade Immunotherapy. Small Methods 5:6.
Crossref
Qin Zhang, Chaowei Gao, Jianqiang Shao & Zunyi Wang. (2021) TIGIT-related transcriptome profile and its association with tumor immune microenvironment in breast cancer. Bioscience Reports 41:3.
Crossref
Ying Yang, Jin Wang, Fei Shi, Aijun Shan, Shihai Xu & Wen Lv. (2021) BDKRB2 is a novel EMT-related biomarker and predicts poor survival in glioma. Aging 13:5, pages 7499-7516.
Crossref
Hao Zhang, Jialin He, Ziyu Dai, Zeyu Wang, Xisong Liang, Fengqiong He, Zhiwei Xia, Songshan Feng, Hui Cao, Liyang Zhang & Quan Cheng. (2021) PDIA5 is Correlated With Immune Infiltration and Predicts Poor Prognosis in Gliomas. Frontiers in Immunology 12.
Crossref
Ying Wang, Jingchuan Wu, Wei Li, Jiankang Li, Raynald Liu, Bao Yang, Chunde Li & Tao Jiang. (2020) Retrospective investigation of hereditary syndromes in patients with medulloblastoma in a single institution. Child's Nervous System 37:2, pages 411-417.
Crossref
Yinnan Meng, Wei Wang, Meng Chen, Kuifei Chen, Xinhang Xia, Suna Zhou & Haihua Yang. (2021) GBP1 Facilitates Indoleamine 2,3-Dioxygenase Extracellular Secretion to Promote the Malignant Progression of Lung Cancer. Frontiers in Immunology 11.
Crossref
Qiang Liu, Bolun Ai, Xiangyi Kong, Xiangyu Wang, Yihang Qi, Zhongzhao Wang, Yi Fang & Jing Wang. (2021) JAK2 expression is correlated with the molecular and clinical features of breast cancer as a favorable prognostic factor. International Immunopharmacology 90, pages 107186.
Crossref
Fangkun Liu, Jing Huang, Xuming Liu, Quan Cheng, Chengke Luo & Zhixiong Liu. (2020) CTLA-4 correlates with immune and clinical characteristics of glioma. Cancer Cell International 20:1.
Crossref
Yangzhi Qi, Baohui Liu, Qian Sun, Xiaoxing Xiong & Qianxue Chen. (2020) Immune Checkpoint Targeted Therapy in Glioma: Status and Hopes. Frontiers in Immunology 11.
Crossref
Qiang Liu, Ran Cheng, Xiangyi Kong, Zhongzhao Wang, Yi Fang & Jing Wang. (2020) Molecular and Clinical Characterization of PD-1 in Breast Cancer Using Large-Scale Transcriptome Data. Frontiers in Immunology 11.
Crossref
Marine Jeanmougin, Annette B. Håvik, Lina Cekaite, Petter Brandal, Anita Sveen, Torstein R. Meling, Trude H. Ågesen, David Scheie, Sverre Heim, Ragnhild A. Lothe & Guro E. Lind. (2020) Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment. Molecular Oncology 14:5, pages 1016-1027.
Crossref
Shujun Liu, Yadi Zhu, Chenxi Zhang, Jiajia Liu, Hong Lv, Guojun Zhang & Xixiong Kang. (2020) Soluble programmed death-1 (sPD-1) and programmed death ligand 1 (sPD-L1) as potential biomarkers for the diagnosis and prognosis of glioma patients. Journal of Medical Biochemistry 39:4, pages 444-451.
Crossref
Enshan Feng, Tingyu Liang, Xiaoyong Wang, Juan Du, Kai Tang, Xiaoxuan Wang, Fang Wang & Gan You. (2019) Correlation of alteration of HLA-F expression and clinical characterization in 593 brain glioma samples. Journal of Neuroinflammation 16:1.
Crossref
Yasuo Takashima, Atsushi Kawaguchi, Azusa Hayano & Ryuya Yamanaka. (2019) CD276 and the gene signature composed of GATA3 and LGALS3 enable prognosis prediction of glioblastoma multiforme. PLOS ONE 14:5, pages e0216825.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.